Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-08-02
2011-08-02
Hui, San-Ming (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S326000, C544S333000
Reexamination Certificate
active
07989458
ABSTRACT:
Compounds of formula (I) in free or salt or solvate form, where T1, T2, Raand Rbhave the meanings as indicated in the specification, are useful for treating inflammatory or obstructive airways, pulmonary hypertension, pulmonary fibrosis, liver fibrosis, muscle diseases and systemic skeletal disorders. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
REFERENCES:
patent: WO 02/47690 (2002-06-01), None
patent: WO 2004/065392 (2004-08-01), None
patent: WO 2004/111036 (2004-12-01), None
patent: WO 2005/058883 (2005-06-01), None
Vippagunta SR, Brittain HG, and Grant D J, “Crystalline solids,” Advanced Drug Delivery Reviews, May 2001,48(1), 3-26.
Adcock Claire
Fairhurst Robin Alec
Leblanc Catherine
Pipet Maude Nadine Pierrette
Pulz Robert Alexander
Hui San-ming
Mueller Philippe
Novartis AG
Smith Michael G.
Zarek Paul
LandOfFree
Pyrimidine derivatives as alk-5 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrimidine derivatives as alk-5 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidine derivatives as alk-5 inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2771094